1. Periodontal regeneration with 0.3% basic fibroblast growth factor (FGF-2) for a patient with aggressive periodontitis: a case report
- Author
-
Kazuhiro Kawamoto, Ryosuke Koshi, Shuichi Sato, Naoto Yoshinuma, Naoyuki Sugano, and Masataka Idesawa
- Subjects
0301 basic medicine ,Adult ,Male ,Basic fibroblast growth factor ,Dentistry ,Placebo ,Fibroblast growth factor ,Placebos ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Aggressive periodontitis ,Humans ,Regeneration ,Periodontitis ,General Dentistry ,Dental alveolus ,business.industry ,Regeneration (biology) ,030206 dentistry ,medicine.disease ,Rate of increase ,Clinical trial ,030104 developmental biology ,chemistry ,Fibroblast Growth Factor 2 ,business - Abstract
This case report describes the clinical efficacy of treatment with basic fibroblast growth factor (FGF-2) for periodontal regeneration. A patient with aggressive periodontitis participated in a clinical trial involving administration of 0.3% FGF-2 in comparison with a placebo control. To evaluate the efficacy of FGF-2, standardized radiographs were taken before surgery and at 12, 24, and 36 weeks after FGF-2 treatment. The rate of increase in alveolar bone height was 86.9% at 36 weeks. The 6-year postoperative radiograph showed significant development of alveolar bone in comparison with the first visit. FGF-2 treatment may be effective for periodontal regeneration in cases of aggressive periodontitis. (J Oral Sci 58, 137-140, 2016).
- Published
- 2016